AQR Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Buy |
+17,973
| New | +$269K | ﹤0.01% | 2920 |
|
|
2024
Q4 | – | Sell |
-35,003
| Closed | -$1.03M | – | 2949 |
|
|
2024
Q3 | $1.03M | Buy |
+35,003
| New | +$1.03M | ﹤0.01% | 1834 |
|
|
2022
Q2 | – | Sell |
-1,471
| Closed | -$85K | – | 2294 |
|
|
2022
Q1 | $85K | Buy |
+1,471
| New | +$85K | ﹤0.01% | 2148 |
|
|
2019
Q4 | – | Sell |
-428
| Closed | -$82K | – | 2173 |
|
|
2019
Q3 | $82K | Sell |
428
-410
| -49% | -$78.6K | ﹤0.01% | 2086 |
|
|
2019
Q2 | $143K | Sell |
838
-294
| -26% | -$50.2K | ﹤0.01% | 2009 |
|
|
2019
Q1 | $228K | Hold |
1,132
| – | – | ﹤0.01% | 2038 |
|
|
2018
Q4 | $212K | Hold |
1,132
| – | – | ﹤0.01% | 2060 |
|
|
2018
Q3 | $271K | Buy |
1,132
+335
| +42% | +$80.2K | ﹤0.01% | 2132 |
|
|
2018
Q2 | $211K | Buy |
+797
| New | +$211K | ﹤0.01% | 2211 |
|